Exhibit 99.1 Interpace Biosciences Announces First Quarter 2025 Financial and Business Results PARSIPPANY, NJ, May 8, 2025 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2025 and provided a business and financial update. First quarter Net Revenue was $11.5 million. Income from continuing operations in the first quarter of 2025 was$1.8 million, a $0.9 million improvement over the prior year q ...